See the DrugPatentWatch profile for Jornay
No direct reviews of Jornay PM are available in the provided text.
What is Jornay PM?
Jornay PM is a once-daily, stimulant medication taken in the evening for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 years and older [1]. It is a dual-phasic stimulant designed to be taken at bedtime and release medication throughout the night and into the morning [1].
How does Jornay PM work?
Jornay PM contains extended-release methylphenidate, a central nervous system stimulant. Its dual-phase release system is engineered to deliver a portion of the dose immediately upon administration and the remainder later in the evening or overnight. This formulation aims to provide symptom control from when the individual wakes up through the afternoon [1].
What are the potential benefits of Jornay PM?
The intended benefit of Jornay PM is to provide consistent symptom control for ADHD throughout the day, starting from morning wakefulness. Its evening dosing regimen is designed to simplify the daily routine for patients and caregivers by eliminating the need for morning stimulant administration [1].
What are the risks associated with Jornay PM?
Like other stimulant medications, Jornay PM carries potential risks. These include the possibility of misuse, abuse, and dependence. It is also associated with cardiovascular risks such as sudden death in individuals with pre-existing serious heart problems or defects. Other potential side effects include psychiatric problems like new or worsened behavioral or thought disorders, and manic symptoms. The medication can also cause or worsen high blood pressure and slow growth in children [1]. Patients should discuss their full medical history, including heart conditions and mental health issues, with their healthcare provider before starting Jornay PM [1].
When might Jornay PM patents expire?
Information regarding the specific patent expiry dates for Jornay PM is not provided. However, patents for brand-name drugs eventually expire, which can open the door for generic or biosimilar competition. Resources like DrugPatentWatch.com track these patent statuses [2].
What are the alternatives to Jornay PM for ADHD treatment?
Treatment for ADHD is individualized. Alternatives to Jornay PM can include other stimulant medications (immediate-release or extended-release formulations of methylphenidate or amphetamines) and non-stimulant medications. Behavioral therapy is also a key component of ADHD management [3].
How is Jornay PM priced?
Pricing information for Jornay PM is not available in the provided text. The cost of prescription medications can vary based on insurance coverage, pharmacy, and other factors.
---
Sources:
[1] https://www.jornaypm.com/
[2] https://drugpatentwatch.com/
[3] https://www.cdc.gov/ncbddd/adhd/treatment.html